For instance, interleukin-1 (IL-1) has been shown to induce chronic inflammation, promoting tumor progression by stimulating processes like epithelial-to-mesenchymal transition, cancer cell proliferation, and the enrichment of immunosuppressive cell populations within the TME57. This evidence concerns the gene IL1B and neoplasm.